A study released by D Yellow Elephant has suggested that both multinational and domestic pharmaceutical firms in particular are increasing the opportunities that digital companies create . Only 30 companies out of 40 companies , have an active LinkedIn presence and only 30 % have a website , highlighting that there is potential for significant growth in this sector .
A study released by D Yellow Elephant has suggested that both multinational and domestic pharmaceutical firms in India are avoiding the opportunities that digital platforms create. Only 14 companies out of 40 polled, have an active LinkedIn presence and only 30% have a website, highlighting that there is room for significant growth in this area.